• 2615 Walden Avenue, Cheektowaga, NY 14225  
  • Tel: 716-825-1935   |   Fax: 716-825-0319   |   Email Us
 
 

Categories

Skip Navigation Links

Browse Special Products

Green Products
Health & Wellness
Cart (0)

Health And Wellness

Welcome to Chudy Paper Health and Wellness Page!  

You will find recent and up to date news and articles posted here periodically.

Check the bottom of the page for other useful and informative links.

 


ISSA: The Value of Clean Infographic (click here)


 

 

 

To: All Distributors
January 29, 2015

 

Measles in the News

From January 1 to January 16, 2015, more than 50 people from six states were reported to have measles. Most of these cases are part of a large, ongoing outbreak linked to an amusement park in California.

The United States experienced a record number of measles cases during 2014, with 644 cases from 27 states reported to CDC's National Center for Immunization and Respiratory Diseases (NCIRD). This is the greatest number of cases since measles elimination was documented in the U.S. in 2000.

 
 

 

What is Measles?

Measles is an acute viral respiratory illness.  It is characterized by a fever followed by a rash. The rash usually appears about 14 days after a person is exposed; however, the incubation period ranges from 7 to 21 days. The rash spreads from the head to the trunk to the lower extremities. Patients are considered to be contagious from 4 days before to 4 days after the rash appears.

It is caused by a single-stranded, enveloped RNA virus with 1 serotype. It is classified as a member of the genus Morbillivirus in the Paramyxoviridae family. Humans are the only natural hosts of measles virus.

How is Measles Spread?

Measles is one of the most contagious of all infectious diseases; approximately 9 out of 10 susceptible persons with close contact to a measles patient will develop measles. The virus is transmitted by direct contact with infectious droplets or by airborne spread when an infected person breathes, coughs, or sneezes. Measles virus can remain infectious on surfaces and in the air for up to two hours after an infected person leaves an area. If other people breathe the contaminated air or touch the infected surface, then touch their eyes, noses, or mouths, they can become infected.

Measles is a disease of humans; measles virus is not spread by any other animal species.

What guidance does the CDC give on preventing the spread of Measles?

Measles can be prevented with measles-containing vaccine, which is primarily administered as the combination measles-mumps-rubella (MMR) vaccine.

The CDC advises that environmental management of measles should include routine cleaning and disinfection.  Special attention should be given to high touch environmental surfaces such as bathtubs, sink fixtures, light fixtures, phones, and hand rails to just name a few.

Specific information can be found here: http://www.cdc.gov/measles/about/index.html

 
 

 


 

Ebola Facts And Prevention Tips

 

Ebola is aptly named for the river adjacent the first recorded outbreak (in 1976), as it has unleashed a steady stream of sickness and death in the recent 2014 Ebola epidemic, the largest ever recorded, even reaching the United States for the first time. 

According to recent IEHA reports, ebola may “incubate” for two to 21 days before victims show symptoms, and – while it is not highly contagious during incubation – its ability to travel “incognito” enables it to reach distant parts of the globe in infected hosts improperly “screened” before they depart the source locale.
 
That is why, more and more, people are being screened at airports by being asked if they feel sick or have been recently exposed to anyone sick or who has died of Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever. Unfortunately, the utility of screening depends largely on the quality and accuracy of the information obtained.
 
The US Centers for Disease Control (CDC) and the World Health Organization (WHO) report that Ebola is transmitted by body fluids of all types (blood, saliva, urine, tears, mother’s milk, semen, etc.) often introduced into a host’s body by touching these fluids and then touching one’s eyes, nose, mouth, or a cut or sore, by ingesting them or via a mucous membrane.
 
It may also be transmitted by touching inanimate surfaces (aka, fomites) where the virus can remain viable for several hours, then touching one’s eyes, nose, mouth, a cut, sore, or a mucous membrane.  Fomites also include textiles such as bedding or clothing contaminated with infectious fluids.
 
Ebola is not generally transmitted through the air unless you are near a victim who is sneezing or coughing without properly covering their nose and mouth, and releasing aerosol droplets carrying the virus that can infect you via exposed eyes, nose, mouth, a cut or sore, etc.
 
People recovered from Ebola can remain infectious for many weeks after symptoms end.
 
Following are additional tips from Dr. Benjamin Tanner,  founder and president of Antimicrobial Test Laboratories, Austin TX:
 
1.    What specific measures should every professional take in light of the possible exposure to EVD, even before symptoms are present? What about PPE?

The level of PPE necessary depends primarily on the stage of disease when contact is made.  Before symptoms arise, people infected with Ebola virus are less contagious (though likely still contagious to some degree), so an ordinary face mask, disposable gloves, a disposable gown, frequent handwashing, and avoiding face-touching are advisable.  Exposure to a person who is showing symptoms of EVD poses a much greater risk.  In those instances I believe the maximum amount of protection available should be utilized, up to positive-pressure biohazard suits.  Knowing how to carefully remove contaminated protective equipment after it is worn is a must.

2.    How should inanimate surfaces be disinfected?

Data suggest that Ebola virus is relatively easy to disinfect and it does not seem to survive for more than about a day when dry on surfaces However, every last viral particle must be killed because the infectious dose is very low.  If a surface is known or suspected of contamination with Ebola virus, I recommend first using an absorbent material (preferably with an incorporated antimicrobial agent) to absorb any liquids that may be present like blood and urine.  The used absorbent material will be highly biohazardous, so it must be disposed of and handled properly.  Then once "gross soil" has been removed, I recommend spraying the surface liberally with a virucidal disinfectant and then letting it stand for the entire contact time listed on the label, or at least five minutes.  The surface should then be wiped with an absorbent cloth and then the cloth should be disposed of as biohazard.  If the surface was contaminated by a person late in the stages of Ebola virus disease, very high numbers of viruses may be present, so I recommend repeating the disinfection step.  In healthcare settings, rooms where the patient has been should be first decontaminated by a whole-room disinfection device, such as those that utilize UV or hydrogen peroxide, then cleaned and disinfected using ordinary disinfectants.

3.    Which EPA-registered disinfectants are effective?

A fresh 1:20 solution of bleach would be my first choice for surface disinfection, though I would expect most EPA-registered virucidal disinfectants to do the job.

4.    What types of “community engagement”  and educational activities are key to successfully preventing or controlling outbreaks?
 
I think educational outreach activities should be focused on individual hygiene improvement and on avoiding contact with those who are infected and showing symptoms.  I think that attempts to mollify the public and downplay the very real (though hopefully small) risk of an outbreak within the United States is counterproductive.

 


Links

New:

http://www.kaivac.com/a_411-Cleaning-School-Cafeterias-to-Avoid-Lingering-Odors

http://www.kaivac.com/a_420-Restroom-Odor-Control-The-Most-Effective-Methods

 

Old:

www.gojo.com/united-states/about-gojo/newsroom/resourcescorp/illness-outbreak.aspx?sc_lang=en

http://www.larsonmiller.com/Suspected%20Ebola%20Patient%20Packaging%20Guidance%20FINAL%20LMI.1.pdf 

  • 2615 Walden Avenue, Cheektowaga, NY 14225  
  • Tel: 716-825-1935   |   Fax: 716-825-0319   |   Email Us